Skip to main content
. 2021 Sep 4;13(9):1406. doi: 10.3390/pharmaceutics13091406

Table 6.

Summary of edaravone CSF PK parameters in beagle dogs.

Group Tmax [15] Cmax (ng/mL) AUC0–24h (ng·h/mL)
B1 1.0 ± 0.0 51.7 ± 9.2 121.4 ± 19.5
B2 0.4 ± 0.1 23.5 ± 7.1 53.4 ± 9.9
B3 0.3 ± 0.0 6.4 ± 2.8 29.1 ± 11.0
B4 2.2 ± 1.6 4.9 ± 2.0 48.0 ± 8.0
B5 0.8 ± 0.3 6.4 ± 1.5 56.8 ± 11.0
B6 1.6 ± 1.6 5.6 ± 1.1 66.9 ± 9.7